Intrinsic Value
Syros Pharmaceuticals, Inc. (SYRS)
$5.35
-0.49 (-8.39%)
Enterprise Value | -697,517.75 |
---|---|
Net Debt | -112.01 |
Equity Value | -697,405.74 |
Shares Outstanding | - |
Equity Value Per Share | -Infinity |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt